EKR Therapeutics' Acquisition

EKR Therapeutics was acquired by Cornerstone Therapeutics on May 16, 2012.

EKR Therapeutics is a specialty pharmaceutical company committed to serving the acute-care hospital setting by identifying, commercializing, and marketing products to address unmet or undersatisfied m…

Articles about EKR Therapeutics' Acquisition: